Abstract
Background
Falls are a ‘geriatric giant’ and are the third leading cause of chronic disability worldwide. About 30% of community-dwellers over the age of 65 experience one or more falls every year leading to significant risk for hospitalization, institutionalization, and even death. As the proportion of older adults increases, falls will place an increasing demand and cost on the health care system. Exercise can effectively and efficiently reduce falls. Specifically, the Otago Exercise Program has demonstrated benefit and cost-effectiveness for the primary prevention of falls in four randomized trials of community-dwelling seniors. Although evidence is mounting, few studies have evaluated exercise for secondary falls prevention (that is, preventing falls among those with a significant history of falls). Hence, we propose a randomized controlled trial powered for falls that will, for the first time, assess the efficacy and efficiency of the Otago Exercise Program for secondary falls prevention.
Methods/Design
A randomized controlled trial among 344 community-dwelling seniors aged 70 years and older who attend a falls prevention clinic to assess the efficacy and the cost-effectiveness of a 12-month Otago Exercise Program intervention as a secondary falls prevention strategy. Participants randomized to the control group will continue to behave as they did prior to study enrolment. The economic evaluation will examine the incremental costs and benefits generated by using the Otago Exercise Program intervention versus the control.
Discussion
The burden of falls is significant. The challenge is to make a difference – to discover effective, ideally cost-effective, interventions that prevent injurious falls that can be readily translated to the population. Our proposal is very practical – the exercise program requires minimal equipment, the physical therapist expertise is widely available, and seniors in Canada and elsewhere have adopted the program and complied with it. Our innovation includes applying the intervention to a targeted high-risk population, aiming to provide the best value for money. Given society’s limited financial resources and the known and increasing burden of falls, there is an urgent need to test this feasible intervention which would be eminently ready for roll out.
Trial registration
ClinicalTrials.gov Protocol Registration System: NCT01029171; registered 7 December 2009.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of British Columbia, Aging, Mobility, and Cognitive Neuroscience Laboratory, Djavad Mowafaghian Centre for Brain Health, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000000122889830)
2 University of British Columbia, Aging, Mobility, and Cognitive Neuroscience Laboratory, Djavad Mowafaghian Centre for Brain Health, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000000122889830); Vancouver Coastal Health Research Institute & University of British Columbia, Centre for Clinical Epidemiology and Evaluation, Vancouver, Canada (GRID:grid.417243.7) (ISNI:0000000403844428)
3 Memorial University of Newfoundland, Health Sciences Centre, School of Pharmacy, St. John’s, Canada (GRID:grid.25055.37) (ISNI:0000000091306822)
4 Vancouver Coastal Health Research Institute & University of British Columbia, Centre for Clinical Epidemiology and Evaluation, Vancouver, Canada (GRID:grid.417243.7) (ISNI:0000000403844428)
5 Vancouver Coastal Health Research Institute & University of British Columbia, Centre for Hip Health and Mobility, Vancouver, Canada (GRID:grid.417243.7) (ISNI:0000000403844428)
6 University of British Columbia, St Paul’s Hospital, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000000122889830)
7 University of Victoria, Behavioural Medicine (BMED) Lab, School of Exercise Science, Physical and Health Education, Victoria, Canada (GRID:grid.143640.4) (ISNI:0000000419369465)
8 Vancouver Coastal Health Research Institute, Vancouver, Canada (GRID:grid.417243.7) (ISNI:0000000403844428)




